Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07476625Not ApplicableNot Yet Recruiting

Efficacy and Safety of Thalidomide for Pediatric PFAPA Syndrome

Role: collaborator

NCT05206799Unknown

The CMCPCTH Research in Chinese Children

Role: collaborator

NCT03933748Unknown

Therapeutic Drug Monitoring of Teicoplanin in Children

Role: collaborator

NCT03953638Unknown

Application of Next Generation Sequencing Technique in Pediatric Bacterial Meningitis

Role: collaborator

All 4 trials loaded